245 related articles for article (PubMed ID: 32342546)
1. Circulating microRNA as biomarkers of canine mammary carcinoma in dogs.
Fish EJ; Martinez-Romero EG; DeInnocentes P; Koehler JW; Prasad N; Smith AN; Bird RC
J Vet Intern Med; 2020 May; 34(3):1282-1290. PubMed ID: 32342546
[TBL] [Abstract][Full Text] [Related]
2. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
[TBL] [Abstract][Full Text] [Related]
3. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
4. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
[TBL] [Abstract][Full Text] [Related]
5. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer.
Wu C; Cao Y; He Z; He J; Hu C; Duan H; Jiang J
Tohoku J Exp Med; 2014 Feb; 232(2):85-95. PubMed ID: 24531034
[TBL] [Abstract][Full Text] [Related]
8. Candidate circulating microRNA biomarkers in dogs with chronic pancreatitis.
Armstrong SK; Hunter RW; Oosthyuzen W; Parys M; Gow AG; Schmitz SS; Dear JW; Mellanby RJ
J Vet Intern Med; 2024; 38(2):995-1004. PubMed ID: 38351718
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999).
Pérez Alenza MD; Tabanera E; Peña L
J Am Vet Med Assoc; 2001 Oct; 219(8):1110-4. PubMed ID: 11700710
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
[TBL] [Abstract][Full Text] [Related]
11. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
[TBL] [Abstract][Full Text] [Related]
12. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study.
Pecile A; Groppetti D; Ferrari R; Grieco V; Giudice C; Spediacci C; Stefanello D; Boracchi P
Res Vet Sci; 2021 Mar; 135():153-161. PubMed ID: 33524825
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.
Jung S; Bohan A
Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980
[TBL] [Abstract][Full Text] [Related]
14. Mammaglobin as a diagnostic serum marker of complex canine mammary carcinomas.
Pandey M; Kumar BV; Verma R
Res Vet Sci; 2015 Dec; 103():187-92. PubMed ID: 26679816
[TBL] [Abstract][Full Text] [Related]
15. Detection of tumor-associated antigens in sera of canine cancer patients by monoclonal antibodies generated against canine mammary carcinoma cells.
Wang J; Brunner CJ; Gangopadhyay A; Bird AC; Wolfe LG
Vet Immunol Immunopathol; 1995 Oct; 48(3-4):193-207. PubMed ID: 8578680
[TBL] [Abstract][Full Text] [Related]
16. Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Theriogenology; 2024 Mar; 217():127-135. PubMed ID: 38271766
[TBL] [Abstract][Full Text] [Related]
17. Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining.
Matos AJ; Faustino AM; Lopes C; Rutteman GR; Gärtner F
Vet Rec; 2006 May; 158(18):626-30. PubMed ID: 16679481
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
19. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation.
Karayannopoulou M; Polizopoulou ZS; Koutinas AF; Fytianou A; Roubies N; Kaldrymidou E; Tsioli V; Patsikas MN; Constantinidis TC; Koutinas CK
Vet Clin Pathol; 2006 Sep; 35(3):287-90. PubMed ID: 16967410
[TBL] [Abstract][Full Text] [Related]
20. Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features.
Estrela-Lima A; Araújo MS; Soares RP; Ribeiro LG; Damasceno KA; Costa AT; Teixeira-Carvalho A; Martins-Filho OA; Cassali GD
Vet Comp Oncol; 2016 Mar; 14(1):88-100. PubMed ID: 24571435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
